| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/A:1018936205485 |
| P698 | PubMed publication ID | 8464811 |
| P2093 | author name string | M Hoffman | |
| P Maincent | |||
| D Sirbat | |||
| L Marchal-Heussler | |||
| P2860 | cites work | The effect of a biodegradable contraceptive capsule (Capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels | Q34259082 |
| Topical ocular drug delivery: recent developments and future challenges | Q39702826 | ||
| Formulation influence on conjunctival penetration of four beta blockers in the pigmented rabbit: a comparison with corneal penetration | Q43806477 | ||
| Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption | Q43897735 | ||
| Congestive heart failure from betaxolol. Case report. | Q54138602 | ||
| A method for the routine intraocular pressure (IOP) measurement in the rabbit: range of IOP variations in this species | Q54455869 | ||
| [Evaluation of the systemic cardiovascular and bronchial effects of beta-blocking eyedrops. Value of isoprenaline and carbachol tests. Therapeutic consequences] | Q68069841 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 386-390 | |
| P577 | publication date | 1993-03-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery | |
| P478 | volume | 10 |
| Q72746331 | Accelerated degradation of poly(epsilon-caprolactone) by organic amines |
| Q89575999 | Advances and limitations of drug delivery systems formulated as eye drops |
| Q77205963 | Comparison of the biodistribution in mice of 111indium oxine encapsulated into poly(lactic-co-glycolic)-D,L-85/15 and poly(epsilon caprolactone) nanocapsules |
| Q44045249 | Design of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. |
| Q44061486 | Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen |
| Q44052992 | Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application |
| Q43653950 | Indomethacin-loaded methoxy poly(ethylene glycol)/ poly(epsilon-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague-Dawley rats. |
| Q74825559 | Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization |
| Q27022253 | Nanomedicine approaches for corneal diseases |
| Q39308820 | Novel Pentablock Copolymers as Thermosensitive Self-Assembling Micelles for Ocular Drug Delivery |
| Q40010634 | Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles. |
| Q41736662 | Ophthalmic drug delivery systems--recent advances |
| Q34312572 | Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs: part 2. In vivo distribution and tumor localization studies |
| Q38549169 | Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers |
| Q42564191 | Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene |
| Q73226771 | Primidone-loaded poly-epsilon-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles |
| Q44893512 | The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers |
| Q39614066 | Toxicogenomics of nanoparticulate delivery of etoposide: potential impact on nanotechnology in retinoblastoma therapy |
Search more.